EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use

Rachel A Rabin, Joseph Farrugia, Ranjini Garani, Romina Mizrahi, Pablo Rusjan

Drug and Alcohol Dependence Reports · 2025-09 · 16 · 100369

DOI: 10.1016/j.dadr.2025.100369 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug and Alcohol Dependence Reports, 2025-09. Verfasst von Rachel A Rabin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Integrated Program in Neuroscience, McGill University, Montreal, Canada. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Mental Health, Fonds de recherche du Quebec Sante.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tobacco is commonly co-used with cannabis. This is unfortunate because tobacco co-use exacerbates select clinical consequences associated with cannabis use. Evidence demonstrates that low levels of anandamide, a prominent endocannabinoid, correlate with worse clinical outcomes. Fatty acid amide hydrolase (FAAH) degrades anandamide, and greater FAAH levels may underlie poorer clinical outcomes in people who co-use relative to those who use only cannabis. Therefore, we tested whether tobacco co-use increases FAAH levels beyond those associated with cannabis use alone. Cannabis-using participants (N = 13) were parsed into individuals with daily tobacco use (CT, n = 5) and no current tobacco use (CAN, n = 8). We evaluated group differences in FAAH, quantified using positron emission tomography and [11C]CURB, while controlling for sex and FAAH genotype in the prefrontal cortex, hippocampus, thalamus, sensorimotor striatum, substantia nigra, and cerebellum. A significant group x ROI interaction for [11C]CURB λk3 [F(5, 45)= 3.15, p = 0.016] emerged. Bonferroni-corrected post-hoc tests indicated greater FAAH levels in CT compared to CAN in the substantia nigra (p = 0.023, d=1.54) and cerebellum (p = 0.003, d=1.76), while a trend emerged in the sensorimotor striatum (p = 0.054, d=1.33). Preliminary findings suggest that tobacco co-use is associated with elevated FAAH activity relative to cannabis-only use, which may underlie poorer clinical outcomes associated with co-use.

Schlagwörter

Stichwörter der Autor:innen

AnandamideCannabisCo-useEndocannabinoidFatty acid amide hydrolaseTobacco

Autor:innen und Institutionen

  • Integrated Program in Neuroscience, McGill University, Montreal, Canada.
  • Department of Psychiatry, McGill University, Montreal, Canada.
  • Douglas Mental Health University Institute, Montreal, Canada.

Förderung

  • National Institute of Mental Health
  • Fonds de recherche du Quebec Sante

Zitieren

APA

Rabin, R. A., Farrugia, J., Garani, R., Mizrahi, R., & Rusjan, P. (2025). A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use. Drug and Alcohol Dependence Reports, 16, 100369. https://doi.org/10.1016/j.dadr.2025.100369

Vancouver

Rabin RA, Farrugia J, Garani R, Mizrahi R, Rusjan P. A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use. Drug and Alcohol Dependence Reports. 2025;16:100369. doi:10.1016/j.dadr.2025.100369

BibTeX
@article{Rabin2025,
  author = {Rabin, Rachel A and Farrugia, Joseph and Garani, Ranjini and Mizrahi, Romina and Rusjan, Pablo},
  title = {A preliminary investigation of tobacco co-use on endocannabinoid activity in people with cannabis use},
  journal = {Drug and Alcohol Dependence Reports},
  year = {2025},
  volume = {16},
  pages = {100369},
  doi = {10.1016/j.dadr.2025.100369}
}
Kostenlos starten →